{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSomatostatin receptor subtype 5 (SSTR5) is widely expressed in a spectrum of endocrine and neuroendocrine tumors, where its distribution has been linked to the regulation of hormone secretion and tumor growth. In several studies, high SSTR5 expression was demonstrated in somatostatinomas, pituitary adenomas (including growth hormone‐ and TSH‐secreting tumors), insulinomas, and other gastroenteropancreatic lesions – findings that have been instrumental in guiding both diagnostic imaging and the use of somatostatin analogs to control hormonal hypersecretion and tumor progression. Differential receptor expression patterns among tumor subtypes have further suggested that the balance of SSTR5 with other SSTR subtypes may help predict the effectiveness of therapeutic agents and inform tailored treatment strategies in conditions such as acromegaly and Cushing’s disease."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the molecular level, SSTR5 operates as a seven‐transmembrane G protein–coupled receptor whose function is intricately regulated by receptor–receptor interactions, post‐translational modifications, and precise intracellular signaling events. SSTR5 can form both homodimers and heterodimers (for example, with SSTR1, SSTR2, or even β₁‐adrenergic receptors), an interplay that modulates its trafficking, receptor internalization, and recycling. Specific intracellular domains—including a PDZ ligand motif that interacts with scaffolding proteins, a conserved DRY motif, and a BBXXB region in the third intracellular loop—are critical for coupling to downstream effectors. Moreover, agonist–induced phosphorylation (mediated via G protein–coupled receptor kinases and subsequently reversed by protein phosphatases) and reversible palmitoylation (by enzymes such as ZDHHC5) fine–tune SSTR5’s capacity to inhibit adenylyl cyclase activity and modulate MAPK and PI3K/AKT pathways."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "25", "end_ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional layers of complexity in SSTR5 biology arise from the emergence of truncated receptor variants and genetic polymorphisms that can markedly alter receptor function and influence tumor behavior. Novel splice variants—such as sst5TMD4—have been identified in various tumor types including pituitary, thyroid, prostate, and breast cancers; these aberrant forms not only disrupt normal somatostatin signaling but are also associated with enhanced cell proliferation, increased invasiveness, and resistance to conventional somatostatin analog therapies. In parallel, polymorphic variants in the SSTR5 gene have been linked to differential hormone levels and may underlie variable responses to treatment, underscoring the potential utility of SSTR5 as both a prognostic biomarker and a therapeutic target in a range of endocrine malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "36", "end_ref": "42"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "M Papotti, M Bongiovanni, M Volante, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Virchows Arch (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00428-002-0609-x"}], "href": "https://doi.org/10.1007/s00428-002-0609-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12021920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12021920"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Daniela Pasquali, Antonio Notaro, Giulio Bonavolonta', et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin receptor genes are expressed in lymphocytes from retroorbital tissues in Graves' disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2002-020790"}], "href": "https://doi.org/10.1210/jc.2002-020790"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12414882"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12414882"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "J Bertherat, F Tenenbaum, K Perlemoine, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2002-021895"}], "href": "https://doi.org/10.1210/jc.2002-021895"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14602773"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14602773"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Cheolyoung Park, Inmyung Yang, Jeongtaek Woo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin (SRIF) receptor subtype 2 and 5 gene expression in growth hormone-secreting pituitary adenomas: the relationship with endogenous srif activity and response to octreotide."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr J (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1507/endocrj.51.227"}], "href": "https://doi.org/10.1507/endocrj.51.227"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15118275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15118275"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Michael Grant, Ramesh C Patel, Ujendra Kumar "}, {"type": "b", "children": [{"type": "t", "text": "The role of subtype-specific ligand binding and the C-tail domain in dimer formation of human somatostatin receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M406276200"}], "href": "https://doi.org/10.1074/jbc.M406276200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15247250"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15247250"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "M Filopanti, C Ronchi, E Ballarè, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2005-0132"}], "href": "https://doi.org/10.1210/jc.2005-0132"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15914528"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15914528"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "M C Zatelli, D Piccin, F Tagliati, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Endocrinol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1677/jme.1.01876"}], "href": "https://doi.org/10.1677/jme.1.01876"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16216913"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16216913"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Pierre Cordelier, Jean-Pierre Estève, Souad Najib, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of neuronal nitric-oxide synthase activity by somatostatin analogs following SST5 somatostatin receptor activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M602024200"}], "href": "https://doi.org/10.1074/jbc.M602024200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16690617"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16690617"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "E Ferrante, C Pellegrini, S Bondioni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr Relat Cancer (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1677/erc.1.01191"}], "href": "https://doi.org/10.1677/erc.1.01191"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16954443"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16954443"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Ai Yoshihara, Osamu Isozaki, Naomi Hizuka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr J (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1507/endocrj.k06-133"}], "href": "https://doi.org/10.1507/endocrj.k06-133"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17159301"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17159301"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Michael Grant, Haydar Alturaihi, Philippe Jaquet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2007-0334"}], "href": "https://doi.org/10.1210/me.2007-0334"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18653781"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18653781"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Heather L Watt, Geetanjali D Kharmate, Ujendra Kumar "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2008.11.012"}], "href": "https://doi.org/10.1016/j.cellsig.2008.11.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19070659"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19070659"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Toru Tateno, Masako Kato, Yuji Tani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr J (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1507/endocrj.k08e-186"}], "href": "https://doi.org/10.1507/endocrj.k08e-186"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19318729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19318729"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Ana Paula M Casarini, Raquel S Jallad, Emília M Pinto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pituitary (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11102-009-0175-1"}], "href": "https://doi.org/10.1007/s11102-009-0175-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19330452"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19330452"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Mario Durán-Prado, Manuel D Gahete, Antonio J Martínez-Fuentes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2008-2564"}], "href": "https://doi.org/10.1210/jc.2008-2564"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19401364"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19401364"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yoshihito Nakayama, Ryuichi Wada, Nobuhisa Yajima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pancreas (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MPA.0b013e3181e78120"}], "href": "https://doi.org/10.1097/MPA.0b013e3181e78120"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20717067"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20717067"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Alessandro Fasciani, Paolo Quilici, Ennio Biscaldi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression and functional relevance of somatostatin receptor-1, -2, and -5 in endometrium and endometriotic lesions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2010-0397"}], "href": "https://doi.org/10.1210/jc.2010-0397"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20739383"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20739383"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Fangyi Gu, Fredrick R Schumacher, Federico Canzian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-10-0507"}], "href": "https://doi.org/10.1158/1055-9965.EPI-10-0507"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20810604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20810604"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Koji Tsuta, Ignacio I Wistuba, Cesar A Moran "}, {"type": "b", "children": [{"type": "t", "text": "Differential expression of somatostatin receptors 1-5 in neuroendocrine carcinoma of the lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2012.05.014"}], "href": "https://doi.org/10.1016/j.prp.2012.05.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22770972"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22770972"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Laura Chinezu, Alexandre Vasiljevic, Emmanuel Jouanneau, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2013.08.007"}], "href": "https://doi.org/10.1016/j.humpath.2013.08.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24182563"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24182563"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Manel Puig-Domingo, Raúl M Luque, Jordi L Reverter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0085527"}], "href": "https://doi.org/10.1371/journal.pone.0085527"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24465589"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24465589"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Baldomero Gonzalez, Guadalupe Vargas, Claudia Ramirez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinol Nutr (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.endonu.2014.05.006"}], "href": "https://doi.org/10.1016/j.endonu.2014.05.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25008035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25008035"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Charlotte Gardair, Mahtab Samimi, Antoine Touzé, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroendocrinology (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000381062"}], "href": "https://doi.org/10.1159/000381062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25765179"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25765179"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Evanthia Diakatou, Krystallenia I Alexandraki, Apostolos V Tsolakis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Endocrinol (Oxf) (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cen.12775"}], "href": "https://doi.org/10.1111/cen.12775"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25808161"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25808161"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Wolf Wente, Thomas Stroh, Alain Beaudet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interactions with PDZ domain proteins PIST/GOPC and PDZK1 regulate intracellular sorting of the somatostatin receptor subtype 5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M507198200"}], "href": "https://doi.org/10.1074/jbc.M507198200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16012170"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16012170"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Erika Peverelli, Andrea G Lania, Giovanna Mantovani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of intracellular signaling mediated by human somatostatin receptor 5: role of the DRY motif and the third intracellular loop."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2008-1785"}], "href": "https://doi.org/10.1210/en.2008-1785"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19342453"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19342453"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Michael Grant, Ujendra Kumar "}, {"type": "b", "children": [{"type": "t", "text": "The role of G-proteins in the dimerisation of human somatostatin receptor types 2 and 5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Regul Pept (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.regpep.2009.08.011"}], "href": "https://doi.org/10.1016/j.regpep.2009.08.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19748526"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19748526"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Nathalie Taquet, Serge Dumont, Jean-Luc Vonesch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential between protein and mRNA expression of CCR7 and SSTR5 receptors in Crohn's disease patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mediators Inflamm (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2009/285812"}], "href": "https://doi.org/10.1155/2009/285812"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20150960"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20150960"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Shota Togawa, Jun Ishii, Atsushi Ishikura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Importance of asparagine residues at positions 13 and 26 on the amino-terminal domain of human somatostatin receptor subtype-5 in signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biochem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jb/mvq022"}], "href": "https://doi.org/10.1093/jb/mvq022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20207824"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20207824"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Rishi K Somvanshi, Sajad A War, Nicole Chaudhari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Receptor specific crosstalk and modulation of signaling upon heterodimerization between β1-adrenergic receptor and somatostatin receptor-5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2011.01.002"}], "href": "https://doi.org/10.1016/j.cellsig.2011.01.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21238583"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21238583"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Yuji Tani, Toru Sugiyama, Hajime Izumiyama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr J (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1507/endocrj.k10e-389"}], "href": "https://doi.org/10.1507/endocrj.k10e-389"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21383526"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21383526"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Geetanjali Kharmate, Padmesh S Rajput, Heather L Watt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2011.03.006"}], "href": "https://doi.org/10.1016/j.bbamcr.2011.03.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21419811"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21419811"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Donghui Li, Motofumi Tanaka, F Charles Brunicardi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cncr.25858"}], "href": "https://doi.org/10.1002/cncr.25858"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21692047"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21692047"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Darja Ciganoka, Inga Balcere, Ivo Kapa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of somatostatin receptor type 5 gene polymorphisms associated with acromegaly."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Endocrinol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1530/EJE-11-0416"}], "href": "https://doi.org/10.1530/EJE-11-0416"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21810856"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21810856"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Tarja Kokkola, Claudia Kruse, Eva-Maria Roy-Pogodzik, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatostatin receptor 5 is palmitoylated by the interacting ZDHHC5 palmitoyltransferase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2011.07.028"}], "href": "https://doi.org/10.1016/j.febslet.2011.07.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21820437"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21820437"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Federico Canzian, James D McKay, Rebecca J Cleveland, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-04-0874"}], "href": "https://doi.org/10.1158/1055-9965.EPI-04-0874"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16214911"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16214911"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Mario Durán-Prado, Alexandru Saveanu, Raul M Luque, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2009-2247"}], "href": "https://doi.org/10.1210/jc.2009-2247"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20233783"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20233783"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Raúl M Luque, Alejandro Ibáñez-Costa, Leonardo Vieira Neto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2015.01.037"}], "href": "https://doi.org/10.1016/j.canlet.2015.01.037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25637790"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25637790"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Daniela Molè, Erica Gentilin, Alejandro Ibañez-Costa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrine (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12020-015-0594-x"}], "href": "https://doi.org/10.1007/s12020-015-0594-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25854304"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25854304"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Miguel Sampedro-Núñez, Raúl M Luque, Ana M Ramos-Levi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6565"}], "href": "https://doi.org/10.18632/oncotarget.6565"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26673010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26673010"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Manuel D Gahete, David Rincón-Fernández, Mario Durán-Prado, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.11076"}], "href": "https://doi.org/10.18632/oncotarget.11076"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27507050"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27507050"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Daniel Hormaechea-Agulla, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.201601264RRR"}], "href": "https://doi.org/10.1096/fj.201601264RRR"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28705809"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28705809"}]}]}]}